Artivila is a computational chemistry-driven drug developer founded by a former Pfizer chief scientist returning to China. It has strong AI-assisted pharmaceutical R&D capabilities. Computational chemistry and AI improve efficiency, support research teams, and increase the likelihood of success. It has established multiple small-molecule immuno-oncology pipelines.
We have received your business plan. After completing an initial evaluation, our investment team will contact projects that align with our investment focus. Due to the volume of submissions, we appreciate your understanding if you do not receive a follow-up. We wish your project every success!
OK
This website uses cookies
This website uses cookies to improve your experience while you navigate through the website. You
can choose to opt-out if you wish. For more information, please refer to our
《Cookies》。
